BR112017007420A2 - compostos aromáticos substituídos e composições farmacêuticas para impedir e tratar diabetes - Google Patents
compostos aromáticos substituídos e composições farmacêuticas para impedir e tratar diabetesInfo
- Publication number
- BR112017007420A2 BR112017007420A2 BR112017007420-6A BR112017007420A BR112017007420A2 BR 112017007420 A2 BR112017007420 A2 BR 112017007420A2 BR 112017007420 A BR112017007420 A BR 112017007420A BR 112017007420 A2 BR112017007420 A2 BR 112017007420A2
- Authority
- BR
- Brazil
- Prior art keywords
- alkenyl
- alkyl
- prevent
- treat diabetes
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
- C07C57/32—Phenylacetic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/52—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
- C07C57/58—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
- C07C59/52—Unsaturated compounds containing hydroxy or O-metal groups a hydroxy or O-metal group being bound to a carbon atom of a six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Child & Adolescent Psychology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462062526P | 2014-10-10 | 2014-10-10 | |
| US62/062,526 | 2014-10-10 | ||
| PCT/CA2015/000531 WO2016054726A1 (en) | 2014-10-10 | 2015-10-08 | Substituted aromatic compounds and pharmaceutical compositions for the prevention and treatment of diabetes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112017007420A2 true BR112017007420A2 (pt) | 2018-01-16 |
Family
ID=55652427
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112017007420-6A BR112017007420A2 (pt) | 2014-10-10 | 2015-10-08 | compostos aromáticos substituídos e composições farmacêuticas para impedir e tratar diabetes |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US10105331B2 (enExample) |
| EP (1) | EP3203998B1 (enExample) |
| JP (1) | JP6676629B2 (enExample) |
| KR (1) | KR20170066614A (enExample) |
| CN (1) | CN106999458B (enExample) |
| AR (1) | AR102248A1 (enExample) |
| AU (1) | AU2015330643B2 (enExample) |
| BR (1) | BR112017007420A2 (enExample) |
| CA (1) | CA2963276A1 (enExample) |
| DK (1) | DK3203998T3 (enExample) |
| ES (1) | ES2875336T3 (enExample) |
| IL (1) | IL251392B (enExample) |
| MX (1) | MX376872B (enExample) |
| PH (1) | PH12017500662B1 (enExample) |
| PL (1) | PL3203998T3 (enExample) |
| PT (1) | PT3203998T (enExample) |
| RU (1) | RU2723486C2 (enExample) |
| SG (1) | SG11201702812PA (enExample) |
| TW (1) | TWI699201B (enExample) |
| UY (1) | UY36354A (enExample) |
| WO (1) | WO2016054726A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2015330643B2 (en) * | 2014-10-10 | 2020-05-14 | Liminal Biosciences Limited | Substituted aromatic compounds and pharmaceutical compositions for the prevention and treatment of diabetes |
| JP6720169B2 (ja) * | 2014-11-12 | 2020-07-08 | リミナル・バイオサイエンシーズ・リミテッドＬｉｍｉｎａｌ ＢｉｏＳｃｉｅｎｃｅｓ Ｌｉｍｉｔｅｄ | 組織の自己修復及び再生のための置換芳香族化合物及び医薬組成物 |
| MA53188A1 (fr) | 2018-10-11 | 2021-12-31 | Basf As | Composés aromatiques et leurs utilisations pharmaceutiques |
| MX2023004137A (es) * | 2020-10-06 | 2023-06-22 | Pharmaceutique Ingenew Inc | Compuestos aromaticos sustituidos y composiciones farmaceuticas de los mismos. |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5635532A (en) * | 1991-10-21 | 1997-06-03 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Compositions and methods for therapy and prevention of pathologies including cancer, AIDS and anemia |
| KR101106631B1 (ko) * | 2003-02-13 | 2012-01-20 | 웰스태트 테러퓨틱스 코포레이션 | 대사 질환의 치료용 화합물 |
| AU2005284798B2 (en) * | 2004-09-15 | 2012-02-02 | The President And Fellows Of Harvard College | Reducing ER stress in the treatment of obesity and diabetes |
| AT509045B1 (de) * | 2010-01-29 | 2011-06-15 | Planta Naturstoffe Vertriebsges M B H | Verbindungen zur behandlung von asthma bronchiale |
| JP2012072136A (ja) * | 2010-09-03 | 2012-04-12 | Erina Co Inc | 細胞内代謝促進用組成物、その組成物を含有する糖代謝又は脂質代謝疾患の予防及び／又は治療用医薬製剤、機能性食品及び健康食品 |
| US20130225683A1 (en) * | 2010-10-27 | 2013-08-29 | Prometic Biosciences Inc. | Compounds and Pharmaceutical Compositions for Uses in Diabetes |
| TWI689490B (zh) * | 2013-03-15 | 2020-04-01 | 英商邊緣生物科技有限公司 | 用於治療纖維化之經取代之芳族化合物及相關方法 |
| AU2015330643B2 (en) * | 2014-10-10 | 2020-05-14 | Liminal Biosciences Limited | Substituted aromatic compounds and pharmaceutical compositions for the prevention and treatment of diabetes |
-
2015
- 2015-10-08 AU AU2015330643A patent/AU2015330643B2/en not_active Ceased
- 2015-10-08 JP JP2017518943A patent/JP6676629B2/ja not_active Expired - Fee Related
- 2015-10-08 PT PT158494450T patent/PT3203998T/pt unknown
- 2015-10-08 DK DK15849445.0T patent/DK3203998T3/da active
- 2015-10-08 MX MX2017004738A patent/MX376872B/es active IP Right Grant
- 2015-10-08 US US15/515,048 patent/US10105331B2/en active Active
- 2015-10-08 BR BR112017007420-6A patent/BR112017007420A2/pt not_active Application Discontinuation
- 2015-10-08 PL PL15849445T patent/PL3203998T3/pl unknown
- 2015-10-08 KR KR1020177012551A patent/KR20170066614A/ko not_active Ceased
- 2015-10-08 CN CN201580066107.9A patent/CN106999458B/zh not_active Expired - Fee Related
- 2015-10-08 CA CA2963276A patent/CA2963276A1/en not_active Abandoned
- 2015-10-08 WO PCT/CA2015/000531 patent/WO2016054726A1/en not_active Ceased
- 2015-10-08 SG SG11201702812PA patent/SG11201702812PA/en unknown
- 2015-10-08 RU RU2017116106A patent/RU2723486C2/ru active
- 2015-10-08 PH PH1/2017/500662A patent/PH12017500662B1/en unknown
- 2015-10-08 EP EP15849445.0A patent/EP3203998B1/en active Active
- 2015-10-08 ES ES15849445T patent/ES2875336T3/es active Active
- 2015-10-12 TW TW104133395A patent/TWI699201B/zh not_active IP Right Cessation
- 2015-10-13 UY UY0001036354A patent/UY36354A/es not_active Application Discontinuation
- 2015-10-13 AR ARP150103296A patent/AR102248A1/es unknown
-
2017
- 2017-03-26 IL IL251392A patent/IL251392B/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| PH12017500662B1 (en) | 2022-08-19 |
| US10105331B2 (en) | 2018-10-23 |
| IL251392A0 (en) | 2017-05-29 |
| TWI699201B (zh) | 2020-07-21 |
| RU2017116106A3 (enExample) | 2019-02-13 |
| UY36354A (es) | 2016-06-01 |
| MX2017004738A (es) | 2017-08-10 |
| EP3203998B1 (en) | 2021-03-10 |
| AU2015330643B2 (en) | 2020-05-14 |
| CA2963276A1 (en) | 2016-04-14 |
| JP6676629B2 (ja) | 2020-04-08 |
| ES2875336T3 (es) | 2021-11-10 |
| PL3203998T3 (pl) | 2021-09-27 |
| DK3203998T3 (da) | 2021-05-31 |
| PH12017500662A1 (en) | 2017-10-02 |
| IL251392B (en) | 2020-11-30 |
| JP2017530182A (ja) | 2017-10-12 |
| CN106999458B (zh) | 2021-04-13 |
| PT3203998T (pt) | 2021-06-07 |
| RU2017116106A (ru) | 2018-11-12 |
| US20170209399A1 (en) | 2017-07-27 |
| RU2723486C2 (ru) | 2020-06-11 |
| CN106999458A (zh) | 2017-08-01 |
| EP3203998A4 (en) | 2018-06-20 |
| MX376872B (es) | 2025-03-07 |
| AR102248A1 (es) | 2017-02-15 |
| EP3203998A1 (en) | 2017-08-16 |
| WO2016054726A1 (en) | 2016-04-14 |
| KR20170066614A (ko) | 2017-06-14 |
| AU2015330643A1 (en) | 2017-05-04 |
| SG11201702812PA (en) | 2017-05-30 |
| TW201618763A (zh) | 2016-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY37363A (es) | Sulfonilureas y compuestos relacionados y sus usos | |
| AR093244A1 (es) | Compuestos de benceno sustituidos utilizables en el tratamiento de trastornos mediados por ezh2 | |
| PH12015502012A1 (en) | Substituted aromatic compounds for the treatment of pulmonary fibrosis, liver fibrosis, skin fibrosis and cardiac fibrosis | |
| MA39995B1 (fr) | Composés destinés à traiter l'amyotrophie spinale | |
| EA201490774A1 (ru) | Новые производные оксазина и их применение при лечении заболевания | |
| NI201100137A (es) | Derivados de sulfonamida | |
| PE20210667A1 (es) | Derivados de benzamida para la inhibicion de la actividad abl1, abl2 y bcr-abl1 | |
| CO6690768A2 (es) | Derivados de triazina-oxadiazoles, útiles como inhibidores de los canales de sodio navi.7 | |
| BR112016002651A2 (pt) | composto, sal farmaceuticamente aceitável de um composto, composição farmacêutica, combinação, formulação farmacêutica, métodos para exterminar uma micobactéria e/ou inibir a replicação das micobactérias, e para tratar uma infecção e uma doença, e, uso de um composto | |
| BR112012003464B8 (pt) | compostos de piranil aril metil benzoquinaozlinona, uso dos mesmos, e, composição farmacêutica | |
| BR112015008717A2 (pt) | composto, composição farmacêutica, método de tratar diabetes do tipo ii, uso do composto de fórmula (i), medicação para o tratamento de diabetes do tipo ii | |
| BR112017007420A2 (pt) | compostos aromáticos substituídos e composições farmacêuticas para impedir e tratar diabetes | |
| BR112015017251A8 (pt) | composições farmacêuticas compreendendo doadores de nitroxil, misturas e usos das referidas composições farmacêuticas | |
| BR112015031878A2 (pt) | composição farmacêutica | |
| BR112014029439A2 (pt) | derivados de ácido salicílico, sal farmaceuticamente aceitável dos mesmos, composição dos mesmos e método de uso dos mesmos | |
| BR112018008544A2 (pt) | composição de formação de película dental durável e usos da mesma | |
| BR112018010107A8 (pt) | Composição farmacêutica para o tratamento ou prevenção de nash | |
| EA201401231A1 (ru) | Фармацевтические комбинации, предназначенные для лечения метаболических нарушений | |
| BR112014001083A8 (pt) | composto, processo para a preparação de um composto, composição farmacêutica, método para o tratamento de doenças e uso de um composto | |
| EA201890448A1 (ru) | Фумагиллиновые спироциклические соединения и конденсированные бициклические соединения и способы их получения и применения | |
| BR112016020556A8 (pt) | compostos, composição farmacêutica, método de modulação da atividade do receptor de grelina, método para o tratamento de uma doença e usos de um composto | |
| UY33568A (es) | Compuestos que interactuan con proteina reguladora de glucocinasa para el tratamiento de diabetes. | |
| BR112015022290A2 (pt) | derivados de heterocíclicos benzo-fundidos úteis como agonistas de gpr120 | |
| BR112014016204A8 (pt) | derivado de sitaxentana | |
| BR112017012965A2 (pt) | derivados de fumagilol |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |